Since CD137 has been shown to be secreted in the serum of colon cancer patients as an immune suppressor molecule [23], we thus explored the possibility that the protein may be present in the sera of pancreatic cancer patients. This evidence concerns the gene TNFRSF9 and malignant colon neoplasm.